Who owns Mersana Therapeutics?
- Ticker: MRSN
- CUSIP Number: 59045l106
Tip: Access positions for across all investors
Analyze quarterly positions in Mersana Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Mersana Therapeutics stock
Who bought or sold Mersana Therapeutics this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
EcoR1 Capital | 19M | $87M | 0% | Mar 2024 |
|
VR Adviser | 11M | $51M | 0% | Mar 2024 |
|
Bain Capital Life Sciences Investors | 8.7M | $39M | 0% | Mar 2024 |
|
BlackRock | 8.1M | $36M | 2% | Mar 2024 |
|
Vanguard Group | 6.3M | $28M | 1% | Mar 2024 |
|
Nextech Invest | 3.9M | $17M | -35% | Mar 2024 |
|
Balyasny Asset Management | 3.7M | $16M | -62% | Mar 2024 |
|
Citadel Advisors | 3.5M | $16M | 76% | Mar 2024 |
|
Rock Springs Capital Management | 3.0M | $14M | -10% | Mar 2024 |
|
Morgan Stanley | 2.9M | $13M | 198% | Mar 2024 |
|
Woodline Partners | 2.9M | $13M | 125% | Mar 2024 |
|
Cormorant Asset Management | 2.6M | $12M | 100% | Mar 2024 |
|
Geode Capital Management | 2.4M | $11M | 9% | Mar 2024 |
|
Deutsche Bank Aktiengesellschaft | 1.6M | $7.1M | 39% | Mar 2024 |
|
Millennium Management | 1.5M | $6.8M | -56% | Mar 2024 |
|
Jpmorgan Chase & Co | 1.4M | $6.4M | 1711% | Mar 2024 |
|
5AM Venture Management | 1.3M | $5.8M | 0% | Mar 2024 |
|
D. E. Shaw & Co | 1.2M | $5.5M | 83% | Mar 2024 |
|
Baker Bros. Advisors | 1.1M | $4.9M | 0% | Mar 2024 |
|
Schonfeld Strategic Advisors | 1.0M | $4.5M | -11% | Mar 2024 |
|
Octagon Capital Advisors | 1.0M | $4.5M | 100% | Mar 2024 |
|
Qube Research & Technologies | 960k | $4.3M | 100% | Mar 2024 |
|
Northern Trust | 945k | $4.2M | -8% | Mar 2024 |
|
Jacobs Levy Equity Management | 810k | $3.6M | -13% | Mar 2024 |
|
Goldman Sachs Group | 673k | $3.0M | 362% | Mar 2024 |
|
Verition Fund Management | 564k | $2.5M | 245% | Mar 2024 |
|
ClariVest Asset Management | 472k | $2.1M | 100% | Mar 2024 |
|
Acadian Asset Management | 469k | $2.1M | 32% | Mar 2024 |
|
UBS O'Connor | 434k | $1.9M | 100% | Mar 2024 |
|
Citigroup | 415k | $1.9M | 2497% | Mar 2024 |
|
Barclays | 409k | $1.8M | 169% | Mar 2024 |
|
Bank of New York Mellon | 379k | $1.7M | -2% | Mar 2024 |
|
Jane Street | 371k | $1.7M | 0% | Mar 2024 |
|
Rafferty Asset Management | 368k | $1.7M | 100% | Mar 2024 |
|
FMR | 326k | $1.5M | -44% | Mar 2024 |
|
Monashee Investment Management | 310k | $1.4M | 100% | Mar 2024 |
|
Charles Schwab Investment Management | 296k | $1.3M | -4% | Mar 2024 |
|
UBS Group | 290k | $1.3M | 89% | Mar 2024 |
|
Susquehanna International | 279k | $1.2M | -11% | Mar 2024 |
|
Cubist Systematic Strategies | 239k | $1.1M | 107% | Mar 2024 |
|
PanAgora Asset Management | 236k | $1.1M | -6% | Mar 2024 |
|
Susquehanna Fundamental Investments | 234k | $1.0M | 100% | Mar 2024 |
|
Bridgeway Capital Management | 232k | $1.0M | -60% | Mar 2024 |
|
Two Sigma Investments | 218k | $976k | 27% | Mar 2024 |
|
Bank of America Corporation | 210k | $939k | 29% | Mar 2024 |
|
Thomas Stevens, CFA" | 197k | $883k | 0% | Mar 2024 |
|
Rhumbline Advisers | 179k | $802k | 12% | Mar 2024 |
|
Two Sigma Advisers | 156k | $698k | 3% | Mar 2024 |
|
Lighthouse Investment Partners | 130k | $580k | 100% | Mar 2024 |
|
Nuveen Asset Management | 123k | $553k | 87% | Mar 2024 |
|
HighVista Strategies | 122k | $548k | 100% | Mar 2024 |
|
Alliancebernstein | 118k | $274k | -10% | Dec 2023 |
|
State of Wisconsin Investment Board | 107k | $477k | 100% | Mar 2024 |
|
HealthInvest Partners AB | 100k | $448k | 100% | Mar 2024 |
|
Susquehanna Portfolio Strategies | 94k | $421k | 100% | Mar 2024 |
|
Bnp Paribas Arbitrage, Snc | 81k | $362k | 90% | Mar 2024 |
|
T. Rowe Price Associates | 80k | $359k | 7% | Mar 2024 |
|
QVT Financial | 63k | $283k | 0% | Mar 2024 |
|
ProFund Advisors | 58k | $261k | 100% | Mar 2024 |
|
Deerfield Management Company | 58k | $258k | 100% | Mar 2024 |
|
Exchange Traded Concepts | 57k | $255k | -42% | Mar 2024 |
|
American International | 55k | $128k | 5% | Dec 2023 |
|
Mirae Asset Global Investments | 54k | $243k | 100% | Mar 2024 |
|
MetLife Investment Advisors | 47k | $108k | 0% | Dec 2023 |
|
Marshall Wace | 38k | $172k | -76% | Mar 2024 |
|
Wells Fargo & Company | 38k | $169k | 22% | Mar 2024 |
|
New York State Common Retirement Fund | 37k | $166k | 0% | Mar 2024 |
|
Ing Investment Management | 37k | $164k | -16% | Mar 2024 |
|
GSA Capital Partners | 35k | $158k | 100% | Mar 2024 |
|
XTX Topco | 34k | $150k | -58% | Mar 2024 |
|
SG Americas Securities | 34k | $150k | -15% | Mar 2024 |
|
Principal Financial Group | 32k | $142k | -5% | Mar 2024 |
|
Walleye Trading | 32k | $141k | 100% | Mar 2024 |
|
Dimensional Fund Advisors | 31k | $140k | -69% | Mar 2024 |
|
Florida State Board of Administration | 27k | $113k | -5% | Mar 2024 |
|
Seaward Management Limited Partnership | 24k | $55k | 0% | Dec 2023 |
|
Jasper Ridge Partners | 23k | $104k | 0% | Mar 2024 |
|
ProShare Advisors | 20k | $89k | -8% | Mar 2024 |
|
NEOS Investment Management | 20k | $87k | 100% | Mar 2024 |
|
Ameriprise Financial | 18k | $80k | 100% | Mar 2024 |
|
NISA Investment Advisors | 18k | $80k | 1% | Mar 2024 |
|
E Fund Management | 17k | $78k | 100% | Mar 2024 |
|
Oxford Asset Management | 17k | $74k | 100% | Mar 2024 |
|
Grimes & Company | 15k | $69k | -2% | Mar 2024 |
|
Hunter Perkins Capital Management | 15k | $67k | -42% | Mar 2024 |
|
Mackenzie Financial | 14k | $62k | 100% | Mar 2024 |
|
Fox Run Management | 12k | $55k | -44% | Mar 2024 |
|
Victory Capital Management | 12k | $54k | -5% | Mar 2024 |
|
Inceptionr | 11k | $50k | 100% | Mar 2024 |
|
California State Teachers Retirement System | 11k | $50k | -89% | Mar 2024 |
|
Legal & General Group | 11k | $50k | -62% | Mar 2024 |
|
Summit Investment Advisors | 9.9k | $44k | 0% | Mar 2024 |
|
Russell Investments | 9.5k | $42k | 977% | Mar 2024 |
|
Simplex Trading | 8.0k | $36k | 38% | Mar 2024 |
|
Advisor Group Holdings | 3.8k | $17k | -1% | Mar 2024 |
|
Amalgamated Bank | 3.8k | $17k | -68% | Mar 2024 |
|
Royal Bank of Canada | 2.5k | $0 | -93% | Mar 2024 |
|
OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 2.4k | $10k | -4% | Mar 2024 |
|
Pacer Advisors | 1.7k | $7.7k | 100% | Mar 2024 |
|
Metropolitan Life Insurance Company | 1.6k | $3.6k | -69% | Dec 2023 |
|
Tower Research Capital | 820.00 | $3.7k | -98% | Mar 2024 |
|
Pnc Financial Services | 200.00 | $896.000000 | 0% | Mar 2024 |
|
North Star Investment Management | 150.00 | $672.000000 | 0% | Mar 2024 |
|
Nelson, Van Denburg & Campbell Wealth Management | 22.00 | $97.999000 | 100% | Mar 2024 |
|
CWM | 5.00 | $0 | 100% | Mar 2024 |
|
Frazier Financial Advisors | 5.00 | $23.000000 | 100% | Mar 2024 |
|
Farther Finance Advisors | 1.00 | $4.000000 | 0% | Mar 2024 |
|
Who sold out of Mersana Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Philosophy Capital Management | Sep 2023 | 2.3M | $3.0M |
Altium Capital Management | Sep 2023 | 1.1M | $1.3M |
Rhenman & Partners Asset Management AB | Sep 2023 | 400k | $508k |
Boothbay Fund Management | Sep 2023 | 341k | $433k |
Readystate Asset Management | Dec 2023 | 295k | $685k |
Hrt Financial | Dec 2023 | 106k | $245k |
Foundations Investment Advisors | Dec 2023 | 102k | $345k |
Amundi | Dec 2023 | 96k | $309k |
ALPS Advisors | Sep 2023 | 89k | $113k |
Harbor Capital Advisors | Dec 2023 | 48k | $110k |
Y-Intercept | Sep 2023 | 45k | $57k |
Man Group | Dec 2023 | 45k | $104k |
Group One Trading | Sep 2023 | 42k | $53k |
AQR Capital Management | Dec 2023 | 32k | $73k |
Point72 Middle East FZE | Dec 2023 | 26k | $59k |
Engineers Gate Manager | Sep 2023 | 25k | $32k |
Virtu Financial | Sep 2023 | 22k | $28k |
Ohio Pers | Dec 2023 | 16k | $37k |
Squarepoint Ops | Dec 2023 | 14k | $32k |
Bayesian Capital Management | Dec 2023 | 12k | $28k |
Graham Capital Management | Dec 2023 | 12k | $27k |
Federated Investors | Sep 2023 | 1.4k | $1.8k |
Advisory Services Network | Dec 2023 | 100.00 | $232.000000 |